Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma

被引：72
|
作者：
Lemieux, B [1 ]
Tartas, S [1 ]
Traulle, C [1 ]
Espinouse, D [1 ]
Thieblemont, C [1 ]
Bouafia, F [1 ]
Alhusein, Q [1 ]
Antal, D [1 ]
Salles, G [1 ]
Coiffier, B [1 ]
机构：
[1] Univ Lyon 1, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Haematol, F-69495 Pierre Benite, France
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷 / 09期
关键词：
non-Hodgkin's lymphoma; rituximab; autologous transplantation;
D O I：
10.1038/sj.bmt.1704467
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
Rituximab, an anti-CD20 monoclonal antibody, is increasingly used in the treatment of B-cell non-Hodgkin's lymphoma. Late-onset neutropenia in relation to rituximab has been recently described. In this report, we present six cases occurring after stem cell transplantation and discuss the potential impact of this complication.
引用
收藏
页码：921 / 923
页数：3
相关论文
共 50 条
  • [1] Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma
    B Lemieux
    S Tartas
    C Traulle
    D Espinouse
    C Thieblemont
    F Bouafia
    Q Alhusein
    D Antal
    G Salles
    B Coiffier
    Bone Marrow Transplantation, 2004, 33 : 921 - 923
  • [2] Late-onset neutropenia in patients treated with rituximab for non-Hodgkin's lymphoma
    Fukuno, Kenji
    Tsurumi, Hisashi
    Ando, Nobuhiro
    Kanemura, Nobuhiro
    Goto, Hideko
    Tanabashi, Shinobu
    Okamoto, Kiyonao
    Moriwaki, Hisataka
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2006, 84 (03) : 242 - 247
  • [3] Late-Onset Neutropenia in Patients Treated with Rituximab for Non-Hodgkin’s Lymphoma
    Kenji Fukuno
    Hisashi Tsurumi
    Nobuhiro Ando
    Nobuhiro Kanemura
    Hideko Goto
    Shinobu Tanabashi
    Kiyonao Okamoto
    Hisataka Moriwaki
    International Journal of Hematology, 2006, 84 : 242 - 247
  • [4] Autologous stem cell transplantation in aggressive non-Hodgkin's lymphoma
    Gisselbrecht, C
    HEMATOLOGY AND CELL THERAPY, 1996, 38 (04) : 297 - 304
  • [5] Rituximab for aggressive non-Hodgkin's lymphomas relapsing or refractory to autologous stem cell transplantation
    Pan, D
    Moskowitz, CH
    Zelenetz, AD
    Straus, D
    Kewalaramani, T
    Noy, A
    Qin, J
    Teruya-Feldstein, J
    Portlock, CS
    CANCER JOURNAL, 2002, 8 (05) : 371 - 376
  • [6] Should rituximab be used prior to autologous stem-cell transplantation for non-Hodgkin's lymphoma?
    Rodriguez, J
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (02): : 74 - 75
  • [7] Autologous stem cell transplantation in follicular non-Hodgkin's lymphoma
    R Pettengell
    Bone Marrow Transplantation, 2002, 29 : S1 - S4
  • [8] Autologous stem cell transplantation in follicular non-Hodgkin's lymphoma
    Pettengell, R
    BONE MARROW TRANSPLANTATION, 2002, 29 (Suppl 1) : S1 - S4
  • [9] Autologous stem-cell transplantation in Hodgkin's and non-Hodgkin's lymphoma
    Greinix, HT
    ACTA MEDICA AUSTRIACA, 2000, 27 : 25 - 29
  • [10] Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma
    Shimoni, A
    Hardan, I
    Avigdor, A
    Yeshurun, M
    Raanani, P
    Ben-Bassat, I
    Nagler, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (03) : 457 - 464
12345